These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22284785)

  • 21. Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization.
    Kao YH; Hock Tan AE; Burgmans MC; Irani FG; Khoo LS; Gong Lo RH; Tay KH; Tan BS; Hoe Chow PK; Eng Ng DC; Whatt Goh AS
    J Nucl Med; 2012 Apr; 53(4):559-66. PubMed ID: 22343503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET Molecular Imaging: A Holistic Review of Current Practice and Emerging Perspectives for Diagnosis, Therapeutic Evaluation and Prognosis in Clinical Oncology.
    Duclos V; Iep A; Gomez L; Goldfarb L; Besson FL
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated PET-CT: evidence-based review of oncology indications.
    Sachelarie I; Kerr K; Ghesani M; Blum RH
    Oncology (Williston Park); 2005 Apr; 19(4):481-90; discussion 490-2, 495-6. PubMed ID: 15934517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The growing development of multimodality imaging in oncology.
    Papathanassiou D; Liehn JC
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):60-5. PubMed ID: 18765183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New PET imaging agents in the management of solid cancers.
    Garcia C; Gebhart G; Flamen P
    Curr Opin Oncol; 2012 Nov; 24(6):748-55. PubMed ID: 22913970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single photon emission tomography/computed tomography (SPET/CT) and positron emission tomography/computed tomography (PET/CT) to image cancer.
    Alberini JL; Edeline V; Giraudet AL; Champion L; Paulmier B; Madar O; Poinsignon A; Bellet D; Pecking AP
    J Surg Oncol; 2011 May; 103(6):602-6. PubMed ID: 21480254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast-enhanced [18 F] fluorodeoxyglucose-positron emission tomography/computed tomography in clinical oncology: tumor-, site-, and question-based comparison with standard positron emission tomography/computed tomography.
    Morbelli S; Conzi R; Campus C; Cittadini G; Bossert I; Massollo M; Fornarini G; Calamia I; Marini C; Fiz F; Ghersi C; Derchi LE; Sambuceti G
    Cancer Imaging; 2014 Apr; 14(1):10. PubMed ID: 25609564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of hybrid SPECT-CT in oncology: current and emerging clinical applications.
    Chowdhury FU; Scarsbrook AF
    Clin Radiol; 2008 Mar; 63(3):241-51. PubMed ID: 18275863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnostic relevance of choline-PET / CT in patients with prostate cancer].
    Zengerling F; Schrader AJ; Schrader M; Jentzmik F
    Aktuelle Urol; 2012 Jan; 43(1):49-54. PubMed ID: 21769763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
    Horger M; Bares R
    Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.
    Eaton BR; Kim HS; Schreibmann E; Schuster DM; Galt JR; Barron B; Kim S; Liu Y; Landry J; Fox T
    J Vasc Interv Radiol; 2014 Feb; 25(2):288-95. PubMed ID: 24269792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing a unified imaging approach for neuroendocrine tumours with the evolution of PET-CT with ⁶⁸Ga-labelled somatostatin analogues: could this be tailored according to specific clinical context and individual patient requirement?
    Basu S
    Nucl Med Commun; 2012 Oct; 33(10):1007-10. PubMed ID: 22850607
    [No Abstract]   [Full Text] [Related]  

  • 35. Quantitative PET/CT scanner performance characterization based upon the society of nuclear medicine and molecular imaging clinical trials network oncology clinical simulator phantom.
    Sunderland JJ; Christian PE
    J Nucl Med; 2015 Jan; 56(1):145-52. PubMed ID: 25525180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography-computed tomography in liver imaging.
    Sharma B; Martin A; Zerizer I
    Semin Ultrasound CT MR; 2013 Feb; 34(1):66-80. PubMed ID: 23395319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
    Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
    Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET/CT of cancer patients: part 1, pancreatic neoplasms.
    Dibble EH; Karantanis D; Mercier G; Peller PJ; Kachnic LA; Subramaniam RM
    AJR Am J Roentgenol; 2012 Nov; 199(5):952-67. PubMed ID: 23096166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The imaging of neuroendocrine tumors using single photon emission computed tomography/computed tomography.
    Upadhyay B; Lu SJ; Navalkissoor S; Gnanasegaran G; Buscombe J
    Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):140-51. PubMed ID: 25719486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of positron emission tomography-computed tomography in pulmonary neoplasms.
    Shreve P; Faasse T
    Radiol Clin North Am; 2013 Sep; 51(5):767-79. PubMed ID: 24010905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.